These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21665554)

  • 21. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
    Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.
    Levy JA; Bergeson J; Putnam K; Rosen V; Cohen R; Lalonde F; Mirza N; Linker G; Sunderland T
    J Int Neuropsychol Soc; 2004 May; 10(3):362-70. PubMed ID: 15147594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences.
    Roses AD
    Ann N Y Acad Sci; 1996 Dec; 802():50-7. PubMed ID: 8993484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
    Marshe VS; Gorbovskaya I; Kanji S; Kish M; Müller DJ
    J Neural Transm (Vienna); 2019 Jan; 126(1):65-85. PubMed ID: 30382407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease.
    McConnell LM; Sanders GD; Owens DK
    Genet Test; 1999; 3(1):47-53. PubMed ID: 10464577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.
    Relkin NR; Kwon YJ; Tsai J; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():149-76. PubMed ID: 8993494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease: clinical implications of the apolipoprotein E genotype.
    Farlow MR
    Neurology; 1997 May; 48(5 Suppl 6):S30-4. PubMed ID: 9153158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer's Prevention Registry.
    Lee AKW; Collier MK; Thompson LI; Popescu D; Arthur E; Correia S; Salloway SP; Alber J
    J Prev Alzheimers Dis; 2023; 10(2):152-161. PubMed ID: 36946441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.
    Berkowitz CL; Mosconi L; Rahman A; Scheyer O; Hristov H; Isaacson RS
    J Prev Alzheimers Dis; 2018; 5(4):245-252. PubMed ID: 30298183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive genetic testing for Alzheimer's disease: impact upon risk perception.
    Marteau TM; Roberts S; LaRusse S; Green RC
    Risk Anal; 2005 Apr; 25(2):397-404. PubMed ID: 15876213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry.
    Alber J; Popescu D; Thompson LI; Tonini GM; Arthur E; Oh H; Correia S; Salloway SP; Lee AK
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):293-301. PubMed ID: 33550928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Langbaum JB; Karlawish J; Roberts JS; Wood EM; Bradbury A; High N; Walsh TL; Gordon D; Aggarwal R; Davis P; Stowell C; Trisko L; Langlois CM; Reiman EM; Tariot PN
    Alzheimers Dement; 2019 Apr; 15(4):515-524. PubMed ID: 30772251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gain of apolipoprotein E genotyping to separate patients with Alzheimer's disease from normal individuals: relevance to community studies.
    Frisoni GB; Geroldi C; Bianchetti A; Binetti G; Trabucchi M
    Dementia; 1996; 7(6):336-42. PubMed ID: 8915040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer's disease dementia: A systematic review and meta-analysis.
    Banning LCP; Ramakers IHGB; Deckers K; Verhey FRJ; Aalten P
    Neurosci Biobehav Rev; 2019 Jan; 96():302-315. PubMed ID: 30513312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.
    Chao S; Roberts JS; Marteau TM; Silliman R; Cupples LA; Green RC
    Alzheimer Dis Assoc Disord; 2008; 22(1):94-7. PubMed ID: 18317253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.
    Eckert SL; Katzen H; Roberts JS; Barber M; Ravdin LD; Relkin NR; Whitehouse PJ; Green RC
    Genet Med; 2006 Dec; 8(12):746-51. PubMed ID: 17172937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E genotyping for pharmacogenetic purposes in Alzheimer's disease: emerging ethical issues.
    Issa AM; Keyserlingk EW
    Can J Psychiatry; 2000 Dec; 45(10):917-22. PubMed ID: 11190361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.
    Green RC; Christensen KD; Cupples LA; Relkin NR; Whitehouse PJ; Royal CD; Obisesan TO; Cook-Deegan R; Linnenbringer E; Butson MB; Fasaye GA; Levinson E; Roberts JS;
    Alzheimers Dement; 2015 Oct; 11(10):1222-30. PubMed ID: 25499536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.
    Mayeux R; Schupf N
    Am J Public Health; 1995 Sep; 85(9):1280-4. PubMed ID: 7661240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.